Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aligos, Amcure, Annovis, Astrazeneca, Atara, BMS, CCT, Cherry, Curevac, Esperion, Greenwich, Handl, Hinova, ICER, Incyte, Jubilant, Kiadis, Morphosys, Nanobiotix, Novartis, Noxopharm, Onethree, Pluristyx, Sareum, Selva, Sierra, Triplet, Tufts, UCB, Vaxart, Vistagen, Wuxi, Xencor, Xilio.